Atherosclerosis measured by B-mode ultrasonography: Effect of statin therapy on disease progression

American Journal of Medicine

Volumn 116, Issue 6 SUPPL. 1, 2004, Pages 31-36

  Kastelein, John J P ^a   De Groot, Eric ^a   Sankatsing, Raaj ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ATORVASTATIN; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; MEVINOLIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PLACEBO; PRAVASTATIN; PROTEIN INHIBITOR; ROSUVASTATIN; SIMVASTATIN;

ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTERY INTIMA; ARTERY WALL; ATHEROSCLEROSIS; CAROTID ARTERY; CLINICAL TRIAL; COHORT ANALYSIS; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ECHOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; OBSERVATION; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY;

ARTERIOSCLEROSIS; CAROTID ARTERIES; DISEASE PROGRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 1642422255     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.02.009     Document Type: Conference Paper

References (25)

1. Labarthe D.R. Epidemiology and Prevention of Cardiovascular Diseases A Global Challenge. 1998;Aspen Publishing, Gaithersburg, MD.
2. Blankenhorn D.H., Hodis H.N. Arterial imaging and atherosclerosis reversal. Arterioscler Thromb. 14:1994;177-192.
3. Poli A., Tremoli E., Colombo A. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients a new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis. 70:1988;253-261.
4. Black D.M. A discussion of modalities for assessing regression and progression in vascular disease. Am J Cardiol. 89:(4A):2002;40B-41B.
5. Bethesda Conference Report. Can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? Proceedings of the 34th Bethesda Conference. J Am Coll Cardiol. 2003;41:1856-1917
6. O'Leary D.H., Polak J.F. Intima-media thickness a tool for atherosclerosis imaging and event prediction. Am J Cardiol. 90:(10C):2002;18L- 21L.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation. 2002;106:3143-3421
8. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 360:2002;7-22.
9. Geroulakos G., O'Gorman D.J., Kalodiki E. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J. 15:1994;781-785.
10. Burke G.L., Evans G.W., Riley W.A., et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults the Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 26:1995;386-391.
11. Chambless L.E., Heiss G., Folsom A.R., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 146:1997;483-494.
12. Bots M.L., Hoes A.W., Koudstaal P.J. Common carotid intima-media thickness and risk of stroke and myocardial infarction the Rotterdam Study. Circulation. 96:1997;1432-1437.
13. Hollander M., Bots M.L., Del Sol A.I., et al. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly the Rotterdam Study. Circulation. 105:2002;2872-2877.
14. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr, for the Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older patients. N Engl J Med 1999;340:14-22
15. Furberg C.D., Adams H.P. Jr, Applegate W.B., et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation. 90:1994;1679-1687.
16. Salonen R., Nyyssönen K., Porkkala E., et al. Kuopio Atherosclerosis Prevention Study (KAPS) a population-based primary prevention trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation. 92:1995;1758-1764.
17. Hodis H.N., Mack W.J., LaBree L., et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy a randomized controlled clinical trial. Ann Intern Med. 124:1996;548-556.
18. de Groot E., Jukema J.W., Montauban van Swijndregt A.D., et al. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings a report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol. 31:1998;1561-1567.
19. Jukema J.W., Bruschke A.V., van Boven A.J., et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels the Regression Growth Evaluation Statin Study (REGRESS). Circulation. 91:1995;2528-2540.
20. Smilde T.J., van Wissen S., Wollersheim H. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP) a prospective, randomised, double-blind trial. Lancet. 357:2001;577-581.
21. Taylor A.J., Kent S.M., Flaherty P.J. ARBITER Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol. A randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation. 106:2002;2055-2060.
22. Crouse JR, Grobbee DE, O'Leary DH, et al. Measuring effects on intima media thickness: an evaluation of rosuvastatin - the METEOR study. Atheroscler Suppl. 2002;3:94. Abstract 136
23. Blasetto J.W., Stein E.A., Brown W.V. Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups. Am J Cardiol. 91:(5A):2003;3C-10C.
24. Olsson A.G., McTaggart F., Raza A. Rosuvastatin a highly effective new HMG-CoA reductase inhibitor. Cardiovasc Drug Rev. 20:2002;303-328.
25. Jones P.H., Davidson M.H., Stein E.A., et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial). Am J Cardiol. 92:2003;152-160.